PL379029A1 - Kompozycje zawierające składnik polisacharydowy i jedną lub większą liczbę warstw powłokowych - Google Patents

Kompozycje zawierające składnik polisacharydowy i jedną lub większą liczbę warstw powłokowych

Info

Publication number
PL379029A1
PL379029A1 PL379029A PL37902904A PL379029A1 PL 379029 A1 PL379029 A1 PL 379029A1 PL 379029 A PL379029 A PL 379029A PL 37902904 A PL37902904 A PL 37902904A PL 379029 A1 PL379029 A1 PL 379029A1
Authority
PL
Poland
Prior art keywords
compositions
coating layers
polysaccharide component
polysaccharide
component
Prior art date
Application number
PL379029A
Other languages
English (en)
Inventor
Graham John Myatt
Paul Alfred Cimiluca
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/369,039 external-priority patent/US20040161471A1/en
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of PL379029A1 publication Critical patent/PL379029A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL379029A 2003-02-18 2004-02-18 Kompozycje zawierające składnik polisacharydowy i jedną lub większą liczbę warstw powłokowych PL379029A1 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US36851403A 2003-02-18 2003-02-18
US36851003A 2003-02-18 2003-02-18
US10/369,039 US20040161471A1 (en) 2003-02-18 2003-02-18 Compositions comprising a plurality of particles or agglomerates having a defined particle size
US10/633,965 US7026303B2 (en) 2003-02-18 2003-08-04 Compositions comprising a polysaccharide component and one or more coating layers

Publications (1)

Publication Number Publication Date
PL379029A1 true PL379029A1 (pl) 2006-06-26

Family

ID=32913221

Family Applications (1)

Application Number Title Priority Date Filing Date
PL379029A PL379029A1 (pl) 2003-02-18 2004-02-18 Kompozycje zawierające składnik polisacharydowy i jedną lub większą liczbę warstw powłokowych

Country Status (9)

Country Link
US (1) US7026303B2 (pl)
EP (1) EP1594463A2 (pl)
JP (1) JP2006515009A (pl)
AR (1) AR043223A1 (pl)
BR (1) BRPI0407548A (pl)
CA (1) CA2514889A1 (pl)
MX (1) MXPA05008790A (pl)
PL (1) PL379029A1 (pl)
WO (1) WO2004073636A2 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8732086B2 (en) 2003-01-02 2014-05-20 Catch Media, Inc. Method and system for managing rights for digital music
CN1886427B (zh) 2003-11-28 2012-05-23 伊士曼化工公司 纤维素共聚体和氧化方法
WO2009036294A1 (en) * 2007-09-14 2009-03-19 Tic Gums, Inc. Super dispersible gums and powders and process for making the same
KR101766619B1 (ko) 2008-12-31 2017-08-08 알데릭스, 인코포레이티드 체액 저류 또는 염 과부하와 연관된 장애 및 위장관 장애의 치료 시에 ｎｈｅ-매개된 역수송을 억제하는 화합물 및 방법
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US20110217426A1 (en) * 2010-03-04 2011-09-08 Perry Stephen C Enteric coating composition
EP2568828B1 (en) 2010-05-08 2016-09-21 Biofiber-Damino A/S Agglomerated oil impregnated psyllium husk
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
HK1211469A1 (en) 2012-08-21 2016-05-27 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
AU2014250956B2 (en) 2013-04-12 2019-04-04 Ardelyx, Inc. NHE3-binding compounds and methods for inhibiting phosphate transport
BR112019013963A2 (pt) 2017-01-09 2020-04-28 Ardelyx Inc inibidores de antiporte mediado por nhe
KR102669987B1 (ko) 2017-01-09 2024-05-31 알데릭스, 인코포레이티드 위장관 장애를 치료하는 데 유용한 화합물
DE102017108054A1 (de) * 2017-04-13 2018-10-18 Natura Werk Gebr. Hiller GmbH & Co. KG Essbare Zusammensetzung zur Verdauungsförderung

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321263A (en) * 1980-09-30 1982-03-23 Rowell Laboratories, Inc. Psyllium compositions
US4548806A (en) * 1982-07-23 1985-10-22 G. D. Searle & Co. Psyllium hydrophilic mucilloid composition
US5009916A (en) * 1983-12-12 1991-04-23 The Procter & Gamble Company Psyllium mucilloid fiber food products
US4999200A (en) * 1987-12-09 1991-03-12 Marion Laboratories Psyllium tablet composition, method of manufacture and method of use
US5219570A (en) * 1989-08-10 1993-06-15 The Procter & Gamble Company Agglomerated psyllium husk containing edible acid
US5320847A (en) * 1993-05-13 1994-06-14 Valentine Enterprises, Inc. Agglomerated psyllium hydrophilic mucilloid combinates
US5356618A (en) * 1993-05-14 1994-10-18 The Procter & Gamble Company Psyllium drink mix compositions
US5424945A (en) * 1993-08-31 1995-06-13 Xerox Corporation System for evaluating a psychological effect of a document
US5651988A (en) 1995-08-18 1997-07-29 Xyrofin Oy Combination osmotic and bulk forming laxatives
US6045847A (en) * 1997-11-13 2000-04-04 Fuji Oil Co., Ltd. Rice cooking method
US6287609B1 (en) * 1999-06-09 2001-09-11 Wisconsin Alumni Research Foundation Unfermented gel fraction from psyllium seed husks
US7014862B2 (en) 2002-05-20 2006-03-21 The Procter & Gamble Company Chewable compositions containing a gel-forming extract of psyllium

Also Published As

Publication number Publication date
EP1594463A2 (en) 2005-11-16
US20040162267A1 (en) 2004-08-19
BRPI0407548A (pt) 2006-02-14
JP2006515009A (ja) 2006-05-18
AR043223A1 (es) 2005-07-20
WO2004073636A3 (en) 2005-04-14
US7026303B2 (en) 2006-04-11
MXPA05008790A (es) 2005-10-18
WO2004073636A2 (en) 2004-09-02
CA2514889A1 (en) 2004-09-02

Similar Documents

Publication Publication Date Title
AU2003258093A8 (en) Diffusion barrier coatings having graded compositions and devices incorporating the same
IL218128A0 (en) Antifungal and antibacterial coating compositions
TWI369385B (en) Liquid-repellent coating composition and coating having high alkali resistance
GB0301034D0 (en) Polymeric film and coating
MX273105B (es) Articulos revestidos y revestimientos de multiples capas.
AU2003225782A1 (en) Fluoropolymer blends and multilayer articles
EP1590501A4 (en) COATING COMPOSITION
EP1652870A4 (en) PHOTORETICULABLE COMPOSITION AND COATING COMPOSITION
EP1566419A4 (en) POWDER COATING
PL373870A1 (pl) Czwartorzędowany polimer osłonięty grupami kwasowymi i kompozycje zawierające taki polimer
TWI373777B (en) Metal coated film, and metal wiring
AU2003241083A1 (en) Animation actuator and related devices
GB2420501B8 (en) A coating composition and articles coated therwith
PL379029A1 (pl) Kompozycje zawierające składnik polisacharydowy i jedną lub większą liczbę warstw powłokowych
ZA200607343B (en) Antifoullng coating composition and its use on man made structures
EP1592824A4 (en) COATING COMPOSITION
GB0215154D0 (en) Coating compositions
GB2422374B (en) Coating compositions
PL378937A1 (pl) Kompozycje zawierające określony składnik polisacharydowy
GB0420751D0 (en) Component coating
AU2003901311A0 (en) Coating compositions
TWI367955B (en) Coating
GB0319781D0 (en) Coating compositions
GB0325942D0 (en) Compositions and uses thereof
GB0207224D0 (en) Tenascin-W compositions and uses thereof

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)